Probiotics, prebiotics and synbiotics- a review

Abstract

The health benefits imparted by probiotics and prebiotics as well as synbiotics have been the subject of extensive research in the past few decades. These food supplements termed as functional foods have been demonstrated to alter, modify and reinstate the pre-existing intestinal flora. They also facilitate smooth functions of the intestinal environment. Most commonly used probiotic strains are: Bifidobacterium, Lactobacilli, S. boulardii, B. coagulans. Prebiotics like FOS, GOS, XOS, Inulin; fructans are the most commonly used fibers which when used together with probiotics are termed synbiotics and are able to improve the viability of the probiotics. Present review focuses on composition and roles of Probiotics, Prebiotics and Synbiotics in human health. Furthermore, additional health benefits like immune-modulation, cancer prevention, inflammatory bowel disease etc. are also discussed.

Pictorial summary of health benefits imparted by probiotics, prebiotics and synbiotics

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ (2005) A combination of prebiotic short-and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 82(2):471–476

    CAS  Google Scholar 

  2. Andrews JM, Tan M (2012) Probiotics in luminal gastroenterology: the current state of play. Intern Med J 42(12):1287–1291

    CAS  Article  Google Scholar 

  3. Artiss JD, Brogan K, Brucal M, Moghaddam M, Jen KLC (2006) The effects of a new soluble dietary fiber on weight gain and selected blood parameters in rats. Metabolism 55(2):195–202, PubMed: 16423626

    CAS  Article  Google Scholar 

  4. Bartlett JG (2002) Antibiotic-associated diarrhea. N Engl J Med 346(5):334–339

    Article  Google Scholar 

  5. Bonnema AL, Kolberg LW, Thomas W, Slavin JL (2010) Gastrointestinal tolerance of chicory inulin products. J Am Diet Assoc 110(6):865–868

    CAS  Article  Google Scholar 

  6. Both E, Gyenge L, Bodor Z, Gyorgy E, Lanyi S, Abraham B (2012) Intensification of probiotic microorganisms viability by microencapsulation using ultrasonic atomizer. UPB Buletin Stiintific Series B: Chem Mater Sc 74(1):27–32, ISSN 1454–2331

    CAS  Google Scholar 

  7. Boyle RJ, Robins-Browne RM, Tang ML (2006) Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83(6):1256–1264

    CAS  Google Scholar 

  8. Cashman K (2003) Prebiotics and calcium bioavailability. Curr Issues Intest Microbiol 4(1):21–32

    CAS  Google Scholar 

  9. Cencic A, Chingwaru W (2010) The role of functional foods, nutraceuticals, and food supplements in intestinal health. Nutrients 2(6):611–625. doi:10.3390/nu2060611, www.mdpi.com/journal/nutrients

    CAS  Article  Google Scholar 

  10. Chapman CMC, Gibson GR, Rowland I (2011) Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr 50(1):1–17

    CAS  Article  Google Scholar 

  11. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D (2008) Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol biol 10(1/2):37

    CAS  Google Scholar 

  12. DeVrese M, Schrezenmeir J (2008) Probiotics, prebiotics, and synbiotics. in food biotechnology (pp. 1–66). Springer Berlin Heidelberg

  13. Erejuwa OO, Sulaiman SA, Wahab MSA (2014) Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. Int J Mol Sci 15(3):4158–4188. doi:10.3390/ijms15034158

    CAS  Article  Google Scholar 

  14. Fotiadis CI, Stoidis CN, Spyropoulos BG, Zografos ED (2008) Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World J Gastroenterol: WJG 14(42):6453, ISSN-1007-9327

    Article  Google Scholar 

  15. Gershon MD (1998) The second brain (pp. 4–7). HarperCollins Publishers

  16. Guglielmetti S, Mora D, Gschwender M, Popp K (2011) Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life––a double‐blind, placebo‐controlled study. Aliment Pharmacol Ther 33(10):1123–1132

    CAS  Article  Google Scholar 

  17. Hardy H, Harris J, Lyon E, Beal J, Foey AD (2013) Probiotics, prebiotics and immunomodulation of gut mucosal defenses: homeostasis and immunopathology. Nutrients 5(6):1869–1912. doi:10.3390/nu5061869, ISSN 2072–6643

    CAS  Article  Google Scholar 

  18. Harish K, Varghese T (2006) Probiotics in humans–evidence based review. Calicut Med J 4(4):e3

    Google Scholar 

  19. Hatakka K, Holma R, El-Nezami H, Suomalainen T, Kuisma M, Saxelin M, Korpela R (2008) The influence of Lactobacillus rhamnosus LC705 together with Propionibacteriumfreudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol 128(2):406–410

    CAS  Article  Google Scholar 

  20. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Shekelle PG (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307(18):1959–1969

    CAS  Article  Google Scholar 

  21. Hill DR, Ryan ET (2008) Management of travellers’ diarrhoea. BMJ, 337

  22. Homayouni A, Payahoo L, Azizi A (2012) Effects of probiotics on lipid profile: a review. Am J Food Technol 7(5)

  23. Hord NG (2008) Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics. Annu Rev Nutr 28:215–231. doi:10.1146/annurev.nutr.28.061807.155402

    CAS  Article  Google Scholar 

  24. Howarth GS (2008) Inflammatory bowel disease, a dysregulated host‐microbiota interaction: are probiotics a new therapeutic option. J Gastroenterol Hepatol 23(12):1777–1779

    Article  Google Scholar 

  25. Hsu CK, Liao JW, Chung YC, Hsieh CP, Chan YC (2004) Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J Nutr 134(6):1523–1528

    CAS  Google Scholar 

  26. Isolauri E, Kirjavainen PV, Salminen S (2002) Probiotics: a role in the treatment of intestinal infection and inflammation. Gut 50(suppl 3):iii54–iii59

    Google Scholar 

  27. Jonkers D, Penders J, Masclee A, Pierik M (2012) Probiotics in the management of inflammatory bowel disease. Drugs 72(6):803–823

    Article  Google Scholar 

  28. Kaufmann SH (2008) Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff. Nat Immunol 9(7):705–712

    CAS  Article  Google Scholar 

  29. Kaur N, Gupta AK (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci 27(7):703–714

    CAS  Article  Google Scholar 

  30. Kelesidis T, Pothoulakis C (2012) Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Ther Adv Gastroenterol 5(2):111–125. doi:10.1177/1756283X11428502

    Article  Google Scholar 

  31. Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Zinsmeister AR (2005) A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neuro-gastroenterology and Motility 17(5):687–696

    CAS  Article  Google Scholar 

  32. Kruis W, Chrubasik S, Boehm S, Stange C, Schulze J (2012) A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. Int J Color Dis 27(4):467–474

    Article  Google Scholar 

  33. Kuo SM (2013) The interplay between fiber and the intestinal microbiome in the inflammatory response. Adv Nutr: Intern Rev J 4(1):16–28. doi:10.3945/an.112.003046

    CAS  Article  Google Scholar 

  34. Lactose Intolerance- Scientific status report 2011 http://www.nationaldairycouncil.org/SiteCollectionDocuments/research/research-summaries/ScientificStatusReportLactoseIntolerance.pdf

  35. Langen LV, Mirjam AC, Dieleman LA (2009) Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis 15(3):454–462

    Article  Google Scholar 

  36. Lee JH, Nam SH, Seo WT, Yun HD, Hong SY, Kim MK, Cho KM (2012) The production of surfactin during the fermentation of cheonggukjang by potential probiotic Bacillus subtilis CSY191 and the resultant growth suppression of MCF-7 human breast cancer cells. Food Chem 131(4):1347–1354

    CAS  Article  Google Scholar 

  37. Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444(7122):1022–1023. doi:10.1038/4441022a

    CAS  Article  Google Scholar 

  38. Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Forbes A (2006) Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut 55(3):348–355

    CAS  Article  Google Scholar 

  39. Liong MT, Dunshea FR, Shah NP (2007) Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high-and low-fat diets. Br J Nutr 98(4):736–744

    CAS  Article  Google Scholar 

  40. Loscalzo J (2011) Lipid metabolism by gut microbes and atherosclerosis. Circ Res 109(2):127–129

    CAS  Article  Google Scholar 

  41. Macfarlane S, Macfarlane GT, Cummings JT (2006) Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 24(5):701–714

    CAS  Article  Google Scholar 

  42. Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Sata M (2005) Probiotic Lactobacillus‐induced improvement in murine chronic inflammatory bowel disease is associated with the down‐regulation of pro‐inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140(3):417–426

    CAS  Article  Google Scholar 

  43. McFarland LV (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101(4):812–822

    Article  Google Scholar 

  44. McFarland LV (2007) Meta-analysis of probiotics for the prevention of traveler'sdiarrhea. Travel Med Infect Dis 5(2):97–105

    Article  Google Scholar 

  45. Moeinian M, FarnazGhasemi-Niri S, Mozaffari S, Abdollahi M (2013) Synergistic effect of probiotics, butyrate and l-Carnitine in treatment of IBD. J Med Hypotheses Ideas 7(2):50–53. doi:10.1016/j.jmhi.2013.02.003

    CAS  Article  Google Scholar 

  46. Narayan SS, Jalgaonkar S, Shahani S, Kulkarni VN (2010) Probiotics: current trends in the treatment of diarrhoea. Hong Kong Med J 16(3):213–218

    Google Scholar 

  47. Nguyen TDT, Kang JH, Lee MS (2007) Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int J Food Microbiol 113(3):358–361

    CAS  Article  Google Scholar 

  48. Niittynen L, Kajander K, Korpela R (2007) Galacto-oligosaccharides and bowel function. Scand J Food Nutr 51(2):62

    Article  Google Scholar 

  49. Oberreuther-Moschner DL, Jahreis G, Rechkemmer G, Pool-Zobel BL (2004) Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. Br J Nutr 91(06):925–932

    CAS  Article  Google Scholar 

  50. Panda AK, Rao SVR, Raju MV, Sharma SR (2006) Dietary supplementation of Lactobacillus sporogenes on performance and serum biochemico-lipid profile of broiler chickens. J Poult Sci 43(3):235–240

    CAS  Article  Google Scholar 

  51. Parnell JA, Reimer RA (2010) Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: a dose–response study in JCR: LA-cp rats. Br J Nutr 103(11):1577–1584. doi:10.1017/S0007114509993539

    CAS  Article  Google Scholar 

  52. Pathak YV (Ed.) (2011) Handbook of nutraceuticals: ingredients, formulations, and applications (Vol. 1). CRC Press

  53. Peña AS (2007) Intestinal flora, probiotics, prebiotics, synbiotics and novel foods. Rev Esp Enferm Dig 99(11):653

    Article  Google Scholar 

  54. Pokusaeva K, Fitzgerald GF, van Sinderen D (2011) Carbohydrate metabolism in Bifidobacteria. Gen Nutr 6(3):285–306. doi:10.1007/s12263-010-0206-6

    CAS  Article  Google Scholar 

  55. Probiotic Lactobacillus, PubMed (2014) homepage http://www.ncbi.nlm.nih.gov/pubmed/?term=probiotic+Lactobacillus

  56. Romeo J, Nova E, Wärnberg J, Gómez-Martínez S, DíazLigia LE, Marcos A (2010) Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages. Nutr Hosp 25(3):341–9

    CAS  Google Scholar 

  57. Roshchina VV (2010) Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells. in Microbial Endocrinol 17–52, Springer New York

  58. Saulnier D, Spinler JK, Gibson GR, Versalovic J (2009) Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 20(2):135–141. doi:10.1016/j.copbio.2009.01.002

    CAS  Article  Google Scholar 

  59. Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Gasbarrini, A (2013) Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. BioMed Res Intern 2013. http://dx.doi.org/10.1155/2013/435268

  60. Schley PD, Field CJ (2002) The immune-enhancing effects of dietary fibres and prebiotics. Br J Nutr 87(S2):S221–S230

    CAS  Article  Google Scholar 

  61. Sheil B, Shanahan F, O’Mahony L (2007) Probiotic effects on inflammatory bowel disease. J Nutr 137(3):819S–824S

    CAS  Google Scholar 

  62. Stienstra R, Tack CJ, Kanneganti TD, Joosten LA, Netea MG (2012) The inflammasome puts obesity in the danger zone. Cell Metab 15(1):10–18

    CAS  Article  Google Scholar 

  63. Sudha R M, Bhonagiri S (2012) Efficacy of Bacillus coagulans strain unique is-2 in the treatment of patients with acute diarrhea. Intern J Probiot Prebiot 7(1)

  64. Sudha MR, Chauhan P, Dixit K, Babu S, Jamil K (2009) Probiotics as complementary therapy for hypercholesterolemia. Biol Med 1(4):1–13, http://www.biolmedonline.com

    CAS  Google Scholar 

  65. Swennen K, Courtin CM, Delcour JA (2006) Non-digestible oligosaccharides with prebiotic properties. Crit Rev Food Sci Nutr 46(6):459–471

    CAS  Article  Google Scholar 

  66. Szajewska H, Horvath A, Piwowarczyk A (2010) Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 32(9):1069–1079

    CAS  Article  Google Scholar 

  67. Szymański H, Pejcz J, Jawień M, Chmielarczyk A, Strus M, Heczko PB (2006) Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains– a randomized, double‐blind, placebo‐controlled trial. Aliment Pharmacol Ther 23(2):247–253

    Article  Google Scholar 

  68. Tanaka Y, Kanazawa M, Fukudo S, Drossman DA (2011) Biopsycho-social model of irritable bowel syndrome. J Neurogastroenterol Motil 17(2):131–139

    Article  Google Scholar 

  69. Teitelbaum JE, Walker WA (2002) Nutritional impact of pre-and probiotics as protective gastrointestinal organisms. Annu Rev Nutr 22(1):107–138

    CAS  Article  Google Scholar 

  70. Van den Abbeele P, Van de Wiele T, Grootaert C, Verstraete W, Gérard P, Bruneau A, Possemiers S (2010) Arabinoxylans and inulin modulate the luminal and mucosa-associated bacteria In vitro and In vivo (pp. 233–249). van der Kamp JW, M. Jones J, McCleary B. V, Topping DL (Eds.). Wageningen Academic Publishers: Waltham, MA, USA

  71. Van Immerseel F, Ducatelle R, De Vos M, Boon N, Van De Wiele T, Verbeke K, Flint HJ (2010) Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol 59(2):141–143. doi:10.1099/jmm.0.017541-0 G 2010

    Article  Google Scholar 

  72. Veerappan GR, Betteridge J, Young PE (2012) Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep 14(4):324–333

    Article  Google Scholar 

  73. Vonk RJ, Reckman GA, Harmsen HJ, Priebe MG (2012) Probiotics and lactose intolerance. http://dx.doi.org/10.5772/51424

  74. Watson RR, Preedy VR (2010) Bioactive foods in promoting health: probiotics and prebiotics. Academic Press

  75. Webb GP(2011) Dietary supplements and functional foods. John Wiley and Sons

  76. Whisner CM, Martin BR, Schoterman MH, Nakatsu CH, McCabe LD, McCabe GP, Weaver CM (2013) Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial. Br J Nutr 110(07):1292–1303

    CAS  Article  Google Scholar 

  77. Zhang MM, Cheng JQ, Lu YR, Yi ZH, Yang P, Wu XT (2010) Use of pre-, pro-and synbiotics in patients with acute pancreatitis: a meta-analysis. World J Gastroenterol: WJG 16(31):3970. doi:10.3748/wjg.v16.i31.3970

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Babu. V. Vakil.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pandey, K.R., Naik, S.R. & Vakil, B.V. Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol 52, 7577–7587 (2015). https://doi.org/10.1007/s13197-015-1921-1

Download citation

Keywords

  • Probiotics
  • Prebiotics
  • Synbiotics
  • Intestinal disorders
  • Cancer
  • Cardiovascular diseases